PM360

JULY 13, 2023

Patients now demand greater access to their health information, desire more communication with their healthcare providers, and seek personalized care tailored to their individual needs. Patients increasingly expect a seamless healthcare experience in which all their health information is integrated and easily accessible.

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Anti-obesity therapeutic landscape. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Anti-obesity therapeutic landscape. million in Q3.

Medical 98

Medical Manufacturing Insurance Side effects 98

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PM360

JUNE 29, 2022

Consumers want companies to help them meet their health and wellness needs, including providing access to innovative products and services that will allow them to live healthier lives. Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer.

Retail 97

Retail Marketing Healthcare Healthcare 97

PM360

SEPTEMBER 21, 2023

aging population, a rise in the net per capita spending on specialty drugs, an increased life expectancy (apart from the impact of COVID), and the increasing prevalence of chronic diseases are expected to boost the specialty pharmaceuticals market to $352 billion by 2027. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

Prescription 52

Prescription Medical Patients Distribution 52